Lastovytska I, Heidenreich S, Klyuchnikov E, Niederwieser C, Gagelmann N, Richter J, Massoud R, Rathje K, Perekhrestenko T, Zeck G, Lück C, Janson D, Wolschke C, Ayuk F, Kröger N. Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantation. haematol [Internet]. 2020Sep.10 [cited 2025Apr.2];. Available from: https://haematologica.org/article/view/11990